SPARC stimulates the synthesis of OPG/OCIF, MMP-2 and DNA in human periodontal ligament cells

被引:21
作者
Fujita, T [1 ]
Shiba, H [1 ]
Sakata, M [1 ]
Uchida, Y [1 ]
Nakamura, S [1 ]
Kurihara, H [1 ]
机构
[1] Hiroshima Univ, Grad Sch Biomed Sci, Dept Periodontal Med, Div Frontier Med Sci,Minami Ku, Hiroshima 7348553, Japan
关键词
ALPase activity; human periodontal ligament cells; MMP-2; OPG; OCIF; SPARC;
D O I
10.1034/j.1600-0714.2002.00188.x
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background: Osteonectin/secreted protein, acidic and rich in cysteine (SPARC) is expressed in periodontal ligaments. Therefore, a better understanding of the action of SPARC on periodontal ligament cells could help to elucidate remodelling and repair mechanisms in periodontal tissue. In the present study, we examined the effects of human platelet-derived SPARC (hp-SPARC) on the expressions of SPARC and osteoprotegerin/osteoclastogenesis inhibitory factor (OPG/OCIF), alkaline phosphatase (ALPase) activity, matrix metalloproteinase-2 (MMP-2) production and DNA synthesis in cultures of human periodontal ligament (HPL) cells. Methods: HPL cells at the sixth passage were exposed to hp-SPARC. The expression of OPG/OCIF and SPARC mRNAs was examined by Northern blot analysis. The protein levels for OPG/OCIF and MMP-2 were determined by Western blot analysis. ALPase activity was measured by the method of Bessey et al. DNA synthesis was estimated by incorporation of [(3) H]thymidine. Results: Hp-SPARC enhanced OPG/OCIF synthesis at the protein and mRNA levels. Hp-SPARC also enhanced DNA and MMP-2 synthesis dose-dependently, but had little effect on ALPase activity and SPARC mRNA expression. Conclusion: SPARC may play a role in remodelling and repair of periodontal tissue by promoting proliferation and MMP-2 production. It may also regulate osteoclast formation through OPG/OCIF in periodontal ligament cells.
引用
收藏
页码:345 / 352
页数:8
相关论文
共 43 条
[1]   Osteoclastogenesis inhibitory factor suppresses osteoclast survival by intetfering in the interaction of stromal cells with osteoclast [J].
Akatsu, T ;
Murakami, T ;
Nishikawa, M ;
Ono, K ;
Shinomiya, N ;
Tsuda, E ;
Mochizuki, S ;
Yamaguchi, K ;
Kinosaki, M ;
Higashio, K ;
Yamamoto, M ;
Motoyoshi, K ;
Nagata, N .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 250 (02) :229-234
[2]  
BESSEY OA, 1946, J BIOL CHEM, V164, P321
[3]   Tumor necrosis factor-α and -β upregulate the levels of osteoprotegerin mRNA in human osteosarcoma MG-63 cells [J].
Brändström, H ;
Jonsson, KB ;
Vidal, O ;
Ljunghall, S ;
Ohlsson, C ;
Ljunggren, Ö .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 248 (03) :454-457
[4]   DIFFERENTIAL-EFFECTS OF SPARC AND CATIONIC SPARC PEPTIDES ON DNA-SYNTHESIS BY ENDOTHELIAL-CELLS AND FIBROBLASTS [J].
FUNK, SE ;
SAGE, EH .
JOURNAL OF CELLULAR PHYSIOLOGY, 1993, 154 (01) :53-63
[5]  
Gilles C, 1998, CANCER RES, V58, P5529
[6]   Mice deficient for the secreted glycoprotein SPARC/osteonectin/BM40 develop normally but show severe age-onset cataract formation and disruption of the lens [J].
Gilmour, DT ;
Lyon, GJ ;
Carlton, MBL ;
Sanes, JR ;
Cunningham, JM ;
Anderson, JR ;
Hogan, BLM ;
Evans, MJ ;
Colledge, WH .
EMBO JOURNAL, 1998, 17 (07) :1860-1870
[7]  
Greenwood JA, 1998, MICROSC RES TECHNIQ, V43, P420, DOI 10.1002/(SICI)1097-0029(19981201)43:5<420::AID-JEMT8>3.0.CO
[8]  
2-B
[9]   Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines [J].
Hofbauer, LC ;
Dunstan, CR ;
Spelsberg, TC ;
Riggs, BL ;
Khosla, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 250 (03) :776-781
[10]   OSTEONECTIN/SPARC REGULATES CELLULAR SECRETION RATES OF FIBRONECTIN AND LAMININ EXTRACELLULAR-MATRIX PROTEINS [J].
KAMIHAGI, K ;
KATAYAMA, M ;
OUCHI, R ;
KATO, I .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 200 (01) :423-428